These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32594934)

  • 21. Abdominal obesity is associated with impaired cognitive function in euthymic bipolar individuals.
    Lackner N; Bengesser SA; Birner A; Painold A; Fellendorf FT; Platzer M; Reininghaus B; Weiss EM; Mangge H; McIntyre RS; Fuchs D; Kapfhammer HP; Wallner-Liebmann SJ; Reininghaus EZ
    World J Biol Psychiatry; 2016 Oct; 17(7):535-46. PubMed ID: 26068130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study.
    Xu G; Lin K; Rao D; Dang Y; Ouyang H; Guo Y; Ma J; Chen J
    J Affect Disord; 2012 Feb; 136(3):328-39. PubMed ID: 22169253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theory of mind impairment and its clinical correlates in patients with schizophrenia, major depressive disorder and bipolar disorder.
    Wang YY; Wang Y; Zou YM; Ni K; Tian X; Sun HW; Lui SSY; Cheung EFC; Suckling J; Chan RCK
    Schizophr Res; 2018 Jul; 197():349-356. PubMed ID: 29122405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive functioning in overweight and obese patients with bipolar disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
    Silveira LE; Kozicky JM; Muralidharan K; Bücker J; Torres IJ; Bond DJ; Kapczinski F; Kauer-Sant'Anna M; Lam RW; Yatham LN
    Can J Psychiatry; 2014 Dec; 59(12):639-48. PubMed ID: 25702364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder.
    Bai YM; Li CT; Tsai SJ; Tu PC; Chen MH; Su TP
    BMC Psychiatry; 2016 Dec; 16(1):448. PubMed ID: 27978821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder.
    Bai YM; Su TP; Tsai SJ; Wen-Fei C; Li CT; Pei-Chi T; Mu-Hong C
    J Affect Disord; 2014 Sep; 166():187-92. PubMed ID: 25012430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
    Goldsmith DR; Rapaport MH; Miller BJ
    Mol Psychiatry; 2016 Dec; 21(12):1696-1709. PubMed ID: 26903267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers.
    Landucci Bonifácio K; Sabbatini Barbosa D; Gastaldello Moreira E; de Farias CC; Higachi L; Camargo AEI; Favaro Soares J; Odebrecht Vargas H; Nunes SOV; Berk M; Dodd S; Maes M
    J Affect Disord; 2017 Nov; 222():185-194. PubMed ID: 28710952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlates of overweight and obesity in 644 patients with bipolar disorder.
    McElroy SL; Frye MA; Suppes T; Dhavale D; Keck PE; Leverich GS; Altshuler L; Denicoff KD; Nolen WA; Kupka R; Grunze H; Walden J; Post RM
    J Clin Psychiatry; 2002 Mar; 63(3):207-13. PubMed ID: 11926719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of peripheral inflammation with body mass index and depressive relapse in bipolar disorder.
    Bond DJ; Andreazza AC; Hughes J; Dhanoa T; Torres IJ; Kozicky JM; Young LT; Lam RW; Yatham LN
    Psychoneuroendocrinology; 2016 Mar; 65():76-83. PubMed ID: 26731572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation, cognitive dysfunction, and suicidal ideation among patients with major depression.
    Huang MH; Chen MH; Hsu JW; Huang KL; Tsai SJ; Su TP; Bai YM
    CNS Spectr; 2022 Dec; 27(6):724-730. PubMed ID: 34423759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Similar profiles of cognitive domain deficits between medication-naïve patients with bipolar II depression and those with major depressive disorder.
    Liu T; Zhong S; Wang B; Liao X; Lai S; Jia Y
    J Affect Disord; 2019 Jan; 243():55-61. PubMed ID: 30227315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-reactive protein and affective inhibition in bipolar disorder.
    Peters AT; Millett CE; Harder J; Potter J; Fichorova R; Nierenberg AA; Burdick KE
    J Affect Disord; 2022 Jun; 306():39-46. PubMed ID: 35248663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circadian preferences, oxidative stress and inflammatory cytokines in bipolar disorder: A community study.
    Mondin TC; de Azevedo Cardoso T; Moreira FP; Wiener C; Oses JP; de Mattos Souza LD; Jansen K; da Silva Magalhães PV; Kapczinski F; da Silva RA
    J Neuroimmunol; 2016 Dec; 301():23-29. PubMed ID: 27836181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder.
    Brietzke E; Stertz L; Fernandes BS; Kauer-Sant'anna M; Mascarenhas M; Escosteguy Vargas A; Chies JA; Kapczinski F
    J Affect Disord; 2009 Aug; 116(3):214-7. PubMed ID: 19251324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder.
    Karagüzel EÖ; Arslan FC; Uysal EK; Demir S; Aykut DS; Tat M; Karahan SC
    Compr Psychiatry; 2019 Feb; 89():61-66. PubMed ID: 30594753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
    Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
    World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of cognitive performance in bipolar disorder: The role of educational degree and inflammatory markers.
    Barbosa IG; Ferreira RA; Rocha NP; Mol GC; da Mata Chiaccjio Leite F; Bauer IE; Teixeira AL
    J Psychiatr Res; 2018 Nov; 106():31-37. PubMed ID: 30261412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls.
    Hope S; Hoseth E; Dieset I; Mørch RH; Aas M; Aukrust P; Djurovic S; Melle I; Ueland T; Agartz I; Ueland T; Westlye LT; Andreassen OA
    Schizophr Res; 2015 Jul; 165(2-3):188-94. PubMed ID: 25956633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body Mass Index Predicts Decline in Executive Function in Bipolar Disorder: Preliminary Data of a 12-Month Follow-up Study.
    Dalkner N; Bengesser S; Birner A; Rieger A; Seebauer J; Platzer M; Hamm C; Maget A; Queissner R; Pilz R; Fellendorf FT; Reininghaus B; Strassnig MT; Kapfhammer HP; Weiss EM; Reininghaus EZ
    Neuropsychobiology; 2021; 80(1):1-11. PubMed ID: 32454501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.